ShervinAssassiMD

PubMed

• EphB2 receptor promotes dermal fibrosis in systemic sclerosis.
  Erika Sa Egal, Severin Donald Kamdem, Masaaki Yoshigi, Ching-Chu Yang, Sarah Pellizzari, Ernest M Kameni, My N Helms, Mark Henkemeyer, Patrice N Mimche, Shervin Assass...> ;Arthritis & Rheumatology. 2024 Apr 8
• Myeloablation followed by hematopoietic stem cell transplantation leads to long-term normalization of systemic sclerosis molecular signatures.
  Nancy Wareing, Xuan Wang, Lynette Keyes-Elstein, Marka A Lyons, Daniel E Furst, Leslie J Crofford, Beverly Welch, Ashley Pinckney, Maureen D Mayes, Keith M Sullivan, E...> ;Arthritis & Rheumatology. 2024 Mar 18
• A Prospective Observational Study of Disease Severity and Mortality in Hispanic American Patients With Systemic Sclerosis.
  Bochra Jandali, Marka Lyons, Julio Charles, Meng Zhang, Samuel Theodore, Claudia Pedroza, Maureen D Mayes, Shervin Assassi> ;Arthritis Care & Research. 2024 Jan 14
• Fibroblast Subpopulations in Systemic Sclerosis: Functional Implications of Individual Subpopulations and Correlations with Clinical Features.
  Zhu, H., Luo, H., Tabib, T., Li, Y., Tao, Y., Matei, A., Lyons, M., Schett, G., Distler, J., Skaug, B., Lafyatis, R., Assassi, S.> ;The Journal of Investigative Dermatology. 2023 Dec 24
• Updates on translational and clinical research in systemic sclerosis.
  Shervin Assassi> ;Current Opinion in Rheumatology. 2023 Nov 1
• Design of a phase III, double-blind, randomised, placebo-controlled trial of BI 1015550 in patients with progressive pulmonary fibrosis (FIBRONEER-ILD).
  Toby M Maher, Shervin Assassi, Arata Azuma, Vincent Cottin, Anna-Maria Hoffmann-Vold, Michael Kreuter, Luca Richeldi, Claudia Valenzuela, Marlies S Wijsenbeek, Carl Co...> ;BMJ Open Respiratory Research. 2023 Sep 1
• Methods for objective assessment of skin involvement in systemic sclerosis.
  Ruhani Desai, Harshdeep Chawla, Kirill Larin, Shervin Assassi> ;Current Opinion in Rheumatology. 2023 Nov 1
• 2 citations
  Combining Clinical and Biological Data to Predict Progressive Pulmonary Fibrosis in Patients With Systemic Sclerosis Despite Immunomodulatory Therapy.
  Elizabeth R Volkmann, Holly Wilhalme, Shervin Assassi, Grace Hyun J Kim, Jonathan Goldin, Masataka Kuwana, Donald P Tashkin, Michael D Roth> ;ACR Open Rheumatology. 2023 Oct 1
• Autoantibody and Cancer Connection in Systemic Sclerosis: Type and Overlap Matter.
  Shervin Assassi> ;Arthritis & Rheumatology. 2024 Jan 1
• Interstitial lung disease in patients with systemic sclerosis: what can we learn from the SENSCIS trial?
  Shervin Assassi, Sudhakar Tumuluri, Robert W Levin> ;Clinical and Experimental Rheumatology. 2023 Aug 1
• 1 citations
  The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the imp...
  Sarah Luebker, Tracy M Frech, Shervin Assassi, Jessica K Gordon, Elana J Bernstein, Virginia D Steen, Ami A Shah, Laura K Hummers, Carrie Richardson, Dinesh Khanna, Fl...> ;Clinical and Experimental Rheumatology. 2023 Aug 1
• Scleroderma Skin: How Is Treatment Best Guided by Data and Implemented in Clinical Practice?
  Madelon C Vonk, Shervin Assassi, Anna-Maria Hoffmann-Vold> ;Rheumatic Diseases Clinics of North America. 2023 May 1
• CONQUER Scleroderma: association of gastrointestinal tract symptoms in early disease with resource utilization.
  Sarah Luebker, Tracy M Frech, Shervin Assassi, Brian Skaug, Jessica K Gordon, Kimberly Lakin, Elana J Bernstein, Yiming Luo, Virginia D Steen, Ami A Shah, Laura K Humm...> ;Rheumatology. 2023 Oct 3
• 2 citations
  Quantitative proteomic screening uncovers candidate diagnostic and monitoring serum biomarkers of ankylosing spondylitis.
  Mark Hwang, Shervin Assassi, Jim Zheng, Jessica Castillo, Reyna Chavez, Kamala Vanarsa, Chandra Mohan, John Reveille> ;Arthritis Research & Therapy. 2023 Apr 11
• 6 citations
  Effect of nintedanib in patients with systemic sclerosis-associated interstitial lung disease and risk factors for rapid progression.
  Dinesh Khanna, Toby M Maher, Elizabeth R Volkmann, Yannick Allanore, Vanessa Smith, Shervin Assassi, Michael Kreuter, Anna-Maria Hoffmann-Vold, Masataka Kuwana, Christ...> ;RMD Open. 2023 Feb 1
• 2 citations
  STAT6 suppression prevents bleomycin-induced dermal fibrosis.
  Jingjing Huang, Hydia Puente, Nancy E Wareing, Minghua Wu, Maureen D Mayes, Harry Karmouty-Quintana, Shervin Assassi, Tingting W Mills> ;FASEB Journal. 2023 Feb 1
• 8 citations
  Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc.
  Chiara Bellocchi, Shervin Assassi, Marka Lyons, Maurizio Marchini, Chandra Mohan, Alessandro Santaniello, Lorenzo Beretta> ;Arthritis Research & Therapy. 2023 Jan 27
• 1 citations
  Reduced digestion of circulating genomic DNA in systemic sclerosis patients with the DNASE1L3 R206C variant.
  Brian Skaug, Xinjian Guo, Yuanteng Jeff Li, Julio Charles, Kay T Pham, Jacob Couturier, Dorothy E Lewis, Claudia Bracaglia, Ivan Caiello, Maureen D Mayes, Shervin Assassi> ;Rheumatology. 2023 Sep 1
• Extensive and Persistent Extravascular Dermal Fibrin Deposition Characterizes Systemic Sclerosis.
  Jeffrey L Browning, Jag Bhawan, Anna Tseng, Nicholas Crossland, Andreea M Bujor, Katerina Akassoglou, Shervin Assassi, Brian Skaug, Jonathan Ho> ;Biorxiv. 2023 Jan 19
• Reactome pathway analysis from whole-blood transcriptome reveals unique characteristics of systemic sclerosis patients at the preclinical stage.
  Chiara Bellocchi, Xuan Wang, Marka A Lyons, Maurizio Marchini, Maurizio Lorini, Vincenzo Carbonelli, Nicola Montano, Lorenzo Beretta, Shervin Assassi> ;Frontiers in Immunology. 2023 Jan 1
• 3 citations
  Three Distinct Transcriptional Profiles of Monocytes Associate with Disease Activity in Scleroderma Patients.
  Hadijat-Kubura M Makinde, Julia L M Dunn, Gaurav Gadhvi, Mary Carns, Kathleen Aren, Anh H Chung, Lutfiyya N Muhammad, Jing Song, Carla M Cuda, Salina Dominguez, John E...> ;Arthritis & Rheumatology. 2023 Apr 1
• 2 citations
  The Effect of Body Fat Distribution on Systemic Sclerosis.
  Gonzalo Villanueva-Martin, Marialbert Acosta-Herrera, Martin Kerick, Elena López-Isac, Carmen P Simeón, José L Callejas, Shervin Assassi, Lorenzo Beretta, Internationa...> ;Journal of Clinical Medicine. 2022 Oct 12
• 4 citations
  Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis.
  Martin Kerick, Marialbert Acosta-Herrera, Carmen Pilar Simeón-Aznar, José Luis Callejas, Shervin Assassi, , Susanna M Proudman, Mandana Nikpour, , , Nicolas Hunzelmann...> ;NPJ Genomic Medicine. 2022 Oct 5
• 5 citations
  Sex differences in clinical outcomes and biological profiles in systemic sclerosis-associated interstitial lung disease: a post-hoc analysis of two randomised controll...
  Elizabeth R Volkmann, Donald P Tashkin, Richard Silver, Carol Feghali Bostwick, Shervin Assassi, DeAnna Baker Frost, Mei Leng, Holly Wilhalme, Grace Hyun Kim, Jonathan...> ;The Lancet. Rheumatology. 2022 Oct 1
• 3 citations
  Safety and tolerability of nintedanib in patients with interstitial lung diseases in subgroups by sex: a post-hoc analysis of pooled data from four randomised controll...
  Hoffmann-Vold, A., Allanore, Y., de Vries-Bouwstra, J., Smith, V., Tschoepe, I., Loaiza, L., Kanakapura, M., Distler, O., Volkmann, E., Assassi, S.> ;The Lancet. Rheumatology. 2022 Oct 1
• Join now to see all

Journal Articles

• The Scleroderma Patient-Centered Intervention Network Cohort: Baseline Clinical Features and Comparison with Other Large Scleroderma Cohorts  
  Daniel E Furst, Robert Spiera, Maureen D Mayes, Lorinda Chung, Suzanne Kafaja, Virginia Steen, Shervin Assassi, Monique Hinchcliff, Rheumatology